Try our Advanced Search for more refined results

PTAB Won't Review Chiesi Unit's 4 Hypertension Drug Patents

By Vin Gurrieri (April 24, 2015, 2:57 PM EDT) -- The Patent Trial and Appeal Board on Friday declined four separate bids by generic drug manufacturer Sandoz Inc. to review four patents owned by a Chiesi USA Inc. unit related to its intravenous high blood pressure drug Cardene because the generic manufacturer failed to show it was likely to prove the patents are invalid....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Attached Documents

Related Sections

Law Firms

Companies

Patents

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!